A staggering 2,313% surge in Elong Power Holding's (NASDAQ: ELPW) share price last week delivered a massive payoff for its largest shareholder group—private equity firms. With concentrated ownership and scant analyst coverage, the stock's dramatic move highlights both its potential and the risks inherent in such thinly followed names.
In Zimbabwe, where formal employment is scarce and medical costs are prohibitive, a stark financial choice is being made: affordable funeral policies are vastly outpacing health insurance, reflecting a cultural prioritization of dignified burials over accessible healthcare.
A landmark investment proposal between AI titans Nvidia and OpenAI has stalled, with both companies reassessing terms amid internal concerns and a shifting competitive landscape, according to a Wall Street Journal report.
Precious metals extended their sharp decline following President Trump's nomination for the next Federal Reserve chair, a move markets interpret as locking in higher interest rates and boosting the U.S. dollar's appeal.
A new financial analysis suggests shares of the documentary-focused streaming service CuriosityStream may be trading significantly below their estimated intrinsic value, presenting a potential opportunity for investors.
Despite a strong three-year run, shares of Ollie's Bargain Outlet (OLLI) dipped this week, prompting investors to weigh its solid earnings growth against recent market performance.
The European CE Mark under the stringent MDR has been granted for Cynosure Lutronic's innovative fractional resurfacing system, designed to improve safety and patient comfort through advanced cooling and precision technology.
While Tesla's stock remains resilient, the promise of a self-driving future presents both staggering potential and significant hurdles for investors to consider.
GXO Logistics has unveiled a series of leadership changes, including the appointment of a new Chief Operating Officer and an interim Chief Accounting Officer, as the company sharpens its focus on operational execution and financial reporting quality amid intense industry competition.
A deep dive into Truist Financial's valuation suggests its current share price may not fully reflect its underlying earnings power and book value, presenting a potential opportunity for investors.
While analyst price targets often paint a rosy picture, a deeper look reveals which recommendations are backed by solid business trends and which may be overly optimistic. We examine one fintech disruptor and one industrial stalwart favored by the Street, alongside a retailer facing significant headwinds.
While recent market surges have lifted several names, discerning investors must separate fleeting hype from durable growth. We analyze two companies capitalizing on structural shifts and one whose valuation appears dangerously disconnected from fundamentals.
Gold and silver prices plunged to multi-year lows as markets reacted to former Fed Governor Kevin Warsh's nomination, signaling a potential shift toward a more hawkish central bank policy and stronger dollar.
Nominee Kevin Warsh's desire to aggressively shrink the Federal Reserve's multi-trillion dollar holdings collides with a financial system now structurally dependent on ample liquidity, making rapid contraction a high-risk endeavor, analysts say.
While EyePoint Pharmaceuticals (EYPT) shares have retreated 23% this month, long-term shareholders are still sitting on massive gains. The biotech's 195% three-year surge, despite ongoing losses, highlights a classic market puzzle: balancing current financials with future potential.
India is negotiating with Ant International to link its Unified Payments Interface (UPI) with the Alipay+ network, a move that could simplify overseas transactions for Indian travelers and signal a thaw in economic relations with China, according to government sources.
While low-volatility stocks offer a haven during market turmoil, their defensive nature can become a liability in bull markets, potentially causing investors to miss out on significant gains. We examine three such stocks and the risks they currently pose.
Identifying companies with sustainable growth engines is a perennial challenge for investors. We analyze three firms—Vertiv, Ares Management, and Halozyme Therapeutics—that are expanding their competitive moats and delivering robust revenue growth, offering potential shelter in uncertain times.
While small-cap stocks offer significant growth potential, their volatility demands careful selection. We analyze one standout and two struggling companies in the Russell 2000 index this week.
While the Russell 2000 index is a hunting ground for high-growth potential, its smaller constituents often carry heightened risks. We examine three specific stocks where valuation concerns and business headwinds suggest investors might want to look elsewhere.
